Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b. / Goodin, Douglas; Reder, Anthony; Traboulsee, Anthony; Li, David; Langdon, Dawn; Cutter, Gary; Cook, Stuart ; O'Donnell, Timothy; Kremenchutzky, Marcelo; Oger, Joel; Koelbach, Ralf; Pohl, Christoph; Wicklein, Eva-Maria.

In: Multiple Sclerosis, Vol. 25, No. 6, 01.05.2019, p. 837-847.

Research output: Contribution to journalArticlepeer-review



  • Douglas Goodin
  • Anthony Reder
  • Anthony Traboulsee
  • David Li
  • Dawn Langdon
  • Gary Cutter
  • Stuart Cook
  • Timothy O'Donnell
  • Marcelo Kremenchutzky
  • Joel Oger
  • Ralf Koelbach
  • Christoph Pohl
  • Eva-Maria Wicklein
Original languageEnglish
Pages (from-to)837-847
Number of pages11
JournalMultiple Sclerosis
Issue number6
Early online date15 May 2018
Publication statusPublished - 1 May 2019
This open access research output is licenced under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

ID: 29849677